Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2024-03-08 Regulatory Filings
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
113年2月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document contains financial data related to loan balances and guarantee information for the company and its subsidiaries, presented in a tabular format. It is a short document (611 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of financial status rather than a full report or announcement of a meeting or voting results. There is no indication of it being an annual or interim report, audit report, or earnings release. The content fits best as a general regulatory announcement or compliance filing that does not fit other specific categories.
2024-03-08 Chinese
113年2月營業收入
Regulatory Filings Classification · 90% confidence The document is a summarized revenue report for a company named 生達, showing monthly and cumulative net operating revenue figures with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (772 characters) and it primarily provides financial summary data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release with highlights. It is a regulatory disclosure of summarized financial data, typical of a Regulatory Filing (RNS) in the context of Taiwanese market disclosures. There is no indication it is an announcement of a report publication or a certification. Therefore, the best fit is Regulatory Filings (RNS).
2024-03-08 Chinese
113年02月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider holdings, confirming it is not a mere announcement or certification.
2024-03-07 Chinese
113年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and executives, with specific numbers of shares held and pledged. It is a disclosure of insider shareholdings and related information. There is no indication of financial results, management discussion, or report publication. The content matches the description of a Director's Dealing report, which involves reporting personal share transactions or holdings by company directors and executives. The document is not a full financial report or announcement but a regulatory disclosure of insider holdings.
2024-03-07 Chinese
112年度應收帳款周轉率
Fund Information / Factsheet Classification · 90% confidence The document is very short (281 characters) and contains financial ratios related to accounts receivable turnover and average collection days for two fiscal years (111 and 112). There is no indication of a full financial report, management discussion, or detailed analysis. The content appears to be a brief financial metric update or a factsheet rather than a comprehensive report. Given the brevity and nature of the data, it fits best as a Fund Information / Factsheet (FS) which typically provides key financial facts and metrics in a concise format.
2024-02-29 Chinese
112年度存貨週轉率
Fund Information / Factsheet Classification · 90% confidence The document is very short (279 characters) and contains inventory turnover ratios and average sales days for two fiscal years (111 and 112). It includes a note about explaining significant changes in inventory turnover rates. There is no indication of a full financial report, management discussion, or regulatory filing. The content is a brief factual summary of key financial metrics, typical of a Fund Information / Factsheet (FS) or a brief financial summary document. Given the brevity and nature of the data, it fits best as a Fund Information / Factsheet (FS).
2024-02-29 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.